Figure legends
Figure 1: Schematic workflow of the molecular tumor board .
Patients are integrated into the molecular tumor board by registration
from the treating physicians. Molecular diagnostics are performed on
either already existing samples or newly acquired biopsies. Results are
discussed in a biweekly interdisciplinary discussion with physicians and
scientists. A treatment recommendation/decision is made either for a
targeted or generalized therapeutic strategy or more diagnostic
follow-up.
Figure 2: Schematic overview of molecular and patho-clinical
data integration towards personalized medicine. Proteomics and
phosphoproteomics provide complementary biological information to
current state-of-the-art molecular diagnostics within the molecular
tumor boards. Integration of genomic and proteomic data promotes
comprehensive molecular characterizations and paves the way toward
personalized medicine and individualized treatment.